Page last updated: 2024-08-23

nitrogenase stabilizing-protective protein, bacteria and (S)-bicalutamide

nitrogenase stabilizing-protective protein, bacteria has been researched along with (S)-bicalutamide in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19901 (14.29)18.7374
1990's0 (0.00)18.2507
2000's4 (57.14)29.6817
2010's1 (14.29)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Chesterson, GJ; Tucker, H1
Dalton, JT; Kirkovsky, L; Miller, DD; Mukherjee, A; Yin, D1
Bohl, CE; Chang, C; Chen, J; Dalton, JT; Miller, DD; Mohler, ML; Swaan, PW1
Lehtovuori, PT; Nyrönen, TH; Söderholm, AA1
Dence, CS; Jenks, C; Katzenellenbogen, JA; Parent, EE; Sharp, TL; Welch, MJ1
Aikawa, K; Baba, A; Hara, T; Hasuoka, A; Ito, M; Kaku, T; Kanzaki, N; Kobayashi, H; Yamamoto, S; Yamaoka, M1
Wang, S; Xiang, W1

Reviews

1 review(s) available for nitrogenase stabilizing-protective protein, bacteria and (S)-bicalutamide

ArticleYear
Therapeutic Strategies to Target the Androgen Receptor.
    Journal of medicinal chemistry, 2022, 07-14, Volume: 65, Issue:13

    Topics: Androgen Antagonists; Androgen Receptor Antagonists; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen

2022

Other Studies

6 other study(ies) available for nitrogenase stabilizing-protective protein, bacteria and (S)-bicalutamide

ArticleYear
Resolution of the nonsteroidal antiandrogen 4'-cyano-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methyl-3'- (trifluoromethyl)-propionanilide and the determination of the absolute configuration of the active enantiomer.
    Journal of medicinal chemistry, 1988, Volume: 31, Issue:4

    Topics: Androgen Antagonists; Anilides; Animals; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Isomerism; Male; Nitriles; Rats; Seminal Vesicles; Tosyl Compounds

1988
Chiral nonsteroidal affinity ligands for the androgen receptor. 1. Bicalutamide analogues bearing electrophilic groups in the B aromatic ring.
    Journal of medicinal chemistry, 2000, Feb-24, Volume: 43, Issue:4

    Topics: Androgen Antagonists; Androgen Receptor Antagonists; Anilides; Animals; Disulfides; In Vitro Techniques; Isothiocyanates; Ligands; Male; Nitriles; Prostate; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Androgen; Stereoisomerism; Structure-Activity Relationship; Sulfones; Tosyl Compounds

2000
A ligand-based approach to identify quantitative structure-activity relationships for the androgen receptor.
    Journal of medicinal chemistry, 2004, Jul-15, Volume: 47, Issue:15

    Topics: Anilides; Heterocyclic Compounds, 3-Ring; Ligands; Models, Molecular; Molecular Conformation; Molecular Structure; Nitriles; Quantitative Structure-Activity Relationship; Quinolines; Receptors, Androgen; Static Electricity; Steroids; Tosyl Compounds

2004
Three-dimensional structure-activity relationships of nonsteroidal ligands in complex with androgen receptor ligand-binding domain.
    Journal of medicinal chemistry, 2005, Feb-24, Volume: 48, Issue:4

    Topics: Anilides; Binding Sites; Flutamide; Imidazolidines; Ligands; Models, Molecular; Nitriles; Quantitative Structure-Activity Relationship; Receptors, Androgen; Tosyl Compounds

2005
Synthesis and biological evaluation of [18F]bicalutamide, 4-[76Br]bromobicalutamide, and 4-[76Br]bromo-thiobicalutamide as non-steroidal androgens for prostate cancer imaging.
    Journal of medicinal chemistry, 2007, Mar-08, Volume: 50, Issue:5

    Topics: Androgen Antagonists; Anilides; Animals; Bromine Radioisotopes; Fluorine Radioisotopes; Isotope Labeling; Ligands; Male; Mice; Neoplasm Transplantation; Nitriles; Prostatic Neoplasms; Radioligand Assay; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Receptors, Androgen; Stereoisomerism; Structure-Activity Relationship; Tissue Distribution; Tosyl Compounds

2007
Design, synthesis, and biological evaluation of 3-aryl-3-hydroxy-1-phenylpyrrolidine derivatives as novel androgen receptor antagonists.
    Bioorganic & medicinal chemistry, 2013, Jan-01, Volume: 21, Issue:1

    Topics: Androgen Receptor Antagonists; Animals; Antineoplastic Agents; Castration; Cell Line, Tumor; Drug Design; Humans; Male; Mice; Models, Molecular; Prostate; Prostatic Neoplasms; Pyrrolidines; Receptors, Androgen; Xenograft Model Antitumor Assays

2013